Department of Orthopedics Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing, China.
Postgrad Med J. 2017 Dec;93(1106):736-742. doi: 10.1136/postgradmedj-2017-134991. Epub 2017 Jul 27.
To collect data of randomised controlled trials (RCTs) and clinical controlled trials (CCTs) for evaluating the effects of enhanced recovery after surgery on postoperative recovery of patients who received total hip arthroplasty (THA) or total knee arthroplasty (TKA).
Relevant, published studies were identified using the following key words: arthroplasty, joint replacement, enhanced recovery after surgery, fast track surgery, multi-mode analgesia, diet management, or steroid hormones. The following databases were used to identify the literature consisting of RCTs or CCTs with a date of search of 31 December 2016: PubMed, Cochrane, Web of knowledge, Ovid SpringerLink and EMBASE. All relevant data were collected from studies meeting the inclusion criteria. The outcome variables were postoperative length of stay (LOS), 30-day readmission rate, and total incidence of complications. RevMan5.2. software was adopted for the meta-analysis.
A total of 10 published studies (9936 cases) met the inclusion criteria. The cumulative data included 4205 cases receiving enhanced recovery after surgery (ERAS), and 5731 cases receiving traditional recovery after surgery (non-ERAS). The meta-analysis showed that LOS was significantly lower in the ERAS group than in the control group (non-ERAS group) (p<0.01), and there were fewer incidences of complications in the ERAS group than in the control group (p=0.03). However, no significant difference was found in the 30-day readmission rate (p=0.18).
ERAS significantly reduces LOS and incidence of complications in patients who have had THA or TKA. However, ERAS does not appear to significantly impact 30-day readmission rates.
收集评价加速康复外科(ERAS)对全髋关节置换术(THA)或全膝关节置换术(TKA)患者术后恢复影响的随机对照试验(RCT)和临床对照试验(CCT)的数据。
使用“关节置换、关节置换术、加速康复外科、快速通道外科、多模式镇痛、饮食管理、甾体激素”等关键词检索相关文献,检索日期截至 2016 年 12 月 31 日,检索数据库包括 PubMed、Cochrane、Web of Knowledge、Ovid SpringerLink、EMBASE。纳入符合标准的 RCT 或 CCT 文献,提取相关数据。观察指标为术后住院时间(LOS)、30 天内再入院率及总并发症发生率。采用 RevMan5.2 软件进行 Meta 分析。
共纳入 10 项研究(9936 例)。汇总数据中,ERAS 组 4205 例,非 ERAS 组(传统康复组)5731 例。Meta 分析结果显示,ERAS 组 LOS 显著低于非 ERAS 组(p<0.01),并发症发生率低于非 ERAS 组(p=0.03),但 30 天内再入院率差异无统计学意义(p=0.18)。
ERAS 可显著减少 THA 或 TKA 患者 LOS 和并发症发生率,但对 30 天内再入院率无显著影响。